Publicação
Concomitant myeloproliferative and lymphoproliferative neoplasms, distinct progenitors : a case report and review of the literature
| dc.contributor.author | Mousinho, Filipa | |
| dc.contributor.author | Santos, Paula | |
| dc.contributor.author | Azevedo, Ana | |
| dc.contributor.author | Pereira, José | |
| dc.contributor.author | Lemos, Raquel | |
| dc.contributor.author | Matos, Sónia | |
| dc.contributor.author | Viana, João | |
| dc.contributor.author | Lima, Fernando | |
| dc.date.accessioned | 2021-06-04T11:19:39Z | |
| dc.date.available | 2021-06-04T11:19:39Z | |
| dc.date.issued | 2018 | |
| dc.description | Copyright © 2018 Spandidos Publications. All rights reserved. | pt_PT |
| dc.description.abstract | Patients with a Philadelphia chromosome-negative myeloproliferative neoplasm may develop a lymphoproliferative disorder; however, the clinical and molecular determinants and the chronological onset of the two events remain unknown. We herein report the case of a 64-year-old man with concomitant diagnosis of high-risk essential thrombocythemia with evidence of a thrombotic event and high-count monoclonal B-cell lymphocytosis (high-count MBL). The patient harbored a JAK2V617F mutation and one of the most common genetic alterations found in chronic lymphocytic leukemia (CLL) (del 13q), which may represent a sign of disease progression. He was initiated on cytoreductive therapy with hydroxyurea 500 mg 3 times per week and hypocoagulation treatment, and is currently under regular surveillance of MBL without CLL criteria. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Mol Clin Oncol. 2018 Sep;9(3):347-349 | pt_PT |
| dc.identifier.doi | 10.3892/mco.2018.1682 | pt_PT |
| dc.identifier.eissn | 2049-9469 | |
| dc.identifier.issn | 2049-9450 | |
| dc.identifier.uri | http://hdl.handle.net/10451/48325 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Spandidos Publications | pt_PT |
| dc.relation.publisherversion | https://www.spandidos-publications.com/mco | pt_PT |
| dc.subject | Myeloproliferative neoplasms | pt_PT |
| dc.subject | Essential thrombocythemia | pt_PT |
| dc.subject | Lymphoproliferative neoplasms | pt_PT |
| dc.subject | Monoclonal B cell lymphocytosis | pt_PT |
| dc.subject | JAK2V617F mutation | pt_PT |
| dc.subject | del(13q) | pt_PT |
| dc.title | Concomitant myeloproliferative and lymphoproliferative neoplasms, distinct progenitors : a case report and review of the literature | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 349 | pt_PT |
| oaire.citation.issue | 3 | pt_PT |
| oaire.citation.startPage | 347 | pt_PT |
| oaire.citation.title | Molecular and Clinical Oncology | pt_PT |
| oaire.citation.volume | 9 | pt_PT |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
Ficheiros
Principais
1 - 1 de 1
Miniatura indisponível
- Nome:
- Concomitant_myeloproliferative.pdf
- Tamanho:
- 265.6 KB
- Formato:
- Adobe Portable Document Format
